To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Guillain-Barre Syndrome Support Group


Woodholme House Ground Floor
Heckington Business Park
Sleaford, NG34 7EB United Kingdom





800 Number



The Guillain-Barre Syndrome Support Group of the United Kingdom is a national voluntary health organization dedicated to providing information, support, and resources to affected individuals, family members, and friends. Guillain-Barre syndrome (GBS) is a rare, rapidly progressive disorder that affects nerves outside the brain and spinal cord (peripheral nervous system). GBS frequently follows an upper respiratory or gastrointestinal infection. The syndrome is characterized by nerve inflammation (polyneuritis) and associated with weakness, tingling and numbness that may rapidly progress to paralysis. Such symptoms initially affect the feet and spread to the trunk, arms, and face. The syndrome often resolves in a few weeks or months, but some residual symptoms may persist for longer periods. Although the exact cause of Guillain-Barre syndrome is unknown, it is thought to result from an abnormal autoimmune response following infection. The Guillain-Barre Syndrome Support Group of the United Kingdom was founded in 1985 and currently consists of approximately 2,000 members. The group is committed to educating affected individuals, healthcare professionals, and the public about Guillain-Barre syndrome. In addition, the group provides educational materials including a regular newsletter entitled "Reaching Out" and several guides such as "GBS: Quick Guide,""The GBS Patient in Intensive Care," and "Other Neuropathies."

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.